Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study

Rosenfeld, 2012, Long-term surveillance of growth hormone therapy, J Clin Endocrinol Metab, 97, 68, 10.1210/jc.2011-2294 Deodati, 2014, Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis, Growth Horm IGF Res, 24, 105, 10.1016/j.ghir.2014.02.001 Swerdlow, 2015, Description of the SAGhE cohort: a large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone, Horm Res Paediatr, 84, 172, 10.1159/000435856 Carel, 2012, Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study, J Clin Endocrinol Metab, 97, 416, 10.1210/jc.2011-1995 Sävendahl, 2012, Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study, J Clin Endocrinol Metab, 97, e213, 10.1210/jc.2011-2882 Swerdlow, 2017, Cancer risks in patients treated with growth hormone in childhood: the SAGhE European cohort study, J Clin Endocrinol Metab, 102, 1661, 10.1210/jc.2016-2046 Clayton, 2007, Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society, J Clin Endocrinol Metab, 92, 804, 10.1210/jc.2006-2017 Breslow, 1980, Statistical methods in cancer research. Volume I—the analysis of case-control studies, IARC Sci Publ, 32, 5 Sävendahl, 2016, Is safety of childhood growth hormone therapy related to dose? Data from a large observational study, Eur J Endocrinol, 174, 681, 10.1530/EJE-15-1017 Mo, 2014, Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the hypopituitary control and complications study (HypoCCS), Pituitary, 17, 477, 10.1007/s11102-013-0529-6 Child, 2019, Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program, J Clin Endocrinol Metab, 104, 379, 10.1210/jc.2018-01189 van Bunderen, 2011, Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults, J Clin Endocrinol Metab, 96, 3151, 10.1210/jc.2011-1215 Quigley, 2017, Mortality in children receiving growth hormone treatment of growth disorders: data from the Genetics and Neuroendocrinology of Short Stature International Study, J Clin Endocrinol Metab, 102, 3195, 10.1210/jc.2017-00214 Wennerström, 2015, Long-term survival of individuals born small and large for gestational age, PLoS One, 10, 10.1371/journal.pone.0138594 Albertsson-Wikland, 2016, Mortality is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics, J Clin Endocrinol Metab, 101, 2149, 10.1210/jc.2015-3951 Gaillard, 2012, Overall and cause-specific mortality in GH-deficient adults on GH replacement, Eur J Endocrinol, 166, 1069, 10.1530/EJE-11-1028 Poidvin, 2014, Growth hormone treatment for childhood short stature and risk of stroke in early adulthood, Neurology, 83, 780, 10.1212/WNL.0000000000000737 Di Somma, 2017, Cardiovascular alterations in adult GH deficiency, Best Pract Res Clin Endocrinol Metab, 31, 25, 10.1016/j.beem.2017.03.005 Barker, 1995, Fetal origins of coronary heart disease, BMJ, 311, 171, 10.1136/bmj.311.6998.171 Kajantie, 2005, Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years, Int J Epidemiol, 34, 655, 10.1093/ije/dyi048 Baker, 2008, Weight at birth and all-cause mortality in adulthood, Epidemiology, 19, 197, 10.1097/EDE.0b013e31816339c6 Risnes, 2011, Birthweight and mortality in adulthood: a systematic review and meta-analysis, Int J Epidemiol, 40, 647, 10.1093/ije/dyq267 Arends, 2005, Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA), Clin Endocrinol (Oxf), 62, 44, 10.1111/j.1365-2265.2004.02171.x Stochholm, 2012, Socioeconomic parameters and mortality in Turner syndrome, Eur J Endocrinol, 166, 1013, 10.1530/EJE-11-1066 Reiss, 1996, Mortality trends in pediatric patients with chronic renal failure, Pediatr Nephrol, 10, 41, 10.1007/BF00863440 Schoemaker, 2008, Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study, Lancet Oncol, 9, 239, 10.1016/S1470-2045(08)70033-0 Fidler, 2016, Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study, BMJ, 354